
Company Info
Year Established2017
Contacts
Ken Kelley, MBACo-Founder & CEO
Company Description
IDBiologics was founded to discover and develop human monoclonal antibodies (mAbs) for the prevention and treatment of infectious diseases.

IDBiologics was founded to discover and develop human monoclonal antibodies (mAbs) for the prevention and treatment of infectious diseases.